Article
Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Mar 2011
Rekhtman Natasha, Brandt Suzanne M, Sigel Carlie S, Friedlander Maria A, Riely Gregory J, Travis William D, Zakowski Maureen F, Moreira Andre L
Abstract excerpt
INTRODUCTION: The two essential requirements for pathologic specimens in the era of personalized therapies for non-small cell lung carcinoma (NSCLC) are accurate subtyping as adenocarcinoma (ADC) versus squamous cell carcinoma (SqCC) and suitability for EGFR and KRAS molecular testing. The aim of this study was to comprehensively review the performance of cytologic specimens for the above two goals in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.